semaglutide cause hypoglycemia Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide and Hypoglycemia: Safety Considerations

Generics usually cost less than brand-name drugs

Wegovy injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU NovoNordisk The European Medicines Agency (EMA) has approved an update to the product information for Wegovy injection that allows the medicine to stay at a controlled temperature of up to 30C for up to 48 hours during delivery, reducing distribution complexity for pharmacies and online partners

Every step, no matter how small, is a step toward healing, strength, and freedom

Association of magnesium intake with sleep duration and sleep quality: findings from the CARDIA study

Your doctor will weigh several critical factors to map out the best path forward